Carnitine

Carnitine – Benefits & Side Effects

Carnitine – Protocol

Carnitine – Lifestyle Considerations

Proper Peptide Storage

Why Proper Peptide Storage Matters

Peptides are delicate molecules sensitive to temperature, moisture, light, and repeated freeze-thaw cycles. Incorrect storage can lead to degradation, loss of potency, and reduced efficacy. Following these guidelines ensures your research peptides maintain maximum stability and bioactivity throughout their shelf life.

Lyophilized (Powder) Peptides

Optimal Storage:

• Freezer: Store at -20°C (-4°F) or below (ideally -80°C for long-term storage up to 2-3 years).
• Short-term: Refrigerate at 2-8°C (35.6-46.4°F) for weeks to months.
• Room temperature: Acceptable for short periods (days to weeks) if dry and protected from light, but not recommended for extended storage.
• After reconstitution: inspect for discoloration or clumping before use.

Key Practices:

• Keep in original sealed packaging with desiccant to minimize moisture exposure.
• Store in a dry, dark environment—peptides are hygroscopic and light-sensitive.
• Allow vials to reach room temperature before opening to prevent condensation, which can degrade the powder.

Reconstituted (Liquid) Peptides

Refrigeration is Essential:

• Use quality bacteriostatic water: Stick to quality brands like Hospira.
• Store at 2-8°C (35.6-46.4°F) immediately after reconstitution.
• Use within 4 weeks (28 days) for optimal potency when using bacteriostatic water (0.9% benzyl alcohol).
• Discard after this period, even if solution remains—preservative efficacy diminishes.

Important Warnings:

• Do NOT freeze reconstituted solutions—freezing denatures peptides.
• Avoid freeze-thaw cycles—they cause irreversible degradation. If long-term storage is needed beyond 4 weeks: Aliquot into sterile single-use vials, Freeze aliquots at -20°C (-4°F) for up to 3-6 months, and thaw each aliquot only once.

Handling Peptides Best Practices

1. Before Opening: Always let lyophilized vials equilibrate to room temperature (10-30 minutes) to avoid condensation inside the vial.
2. Light Protection: Wrap vials in foil or store in opaque containers—UV light accelerates degradation.
3. Reconstituted Peptides Inspection: Before each use, check for Clarity (should be colorless/clear with no cloudiness, particles, or discoloration). Discard if any issues observed.
4. Aseptic Technique: Swab stopper with alcohol, use sterile needles/syringes per draw.
5. Labeling: Mark reconstitution date on vials.

Common Peptide Storage Mistakes to Avoid

• Moisture Exposure: Never store open vials; always reseal tightly.
• Temperature Fluctuations: Avoid door storage in fridge/freezer.
• Heat/Light: Keep away from direct sunlight, heaters, or lab lights.
• Overuse of Multi-Dose Vials: Follow 28-day rule per USP/CDC guidelines.
• Freezing Liquids: Repeated cycles can reduce potency by 25%+ per cycle.

Special Peptide Considerations

• Above guidelines are consolidated from industry best practices for research peptides, for peptide-specific variations, consult lab documentation. Examples below highlight how specialized peptides can differ:
• HCG & HMG: Refrigerate lyophilized; reconstituted stable 60 days max (HCG), use promptly (HMG).
• NAD+: Extremely hygroscopic—use -80°C for powder; refrigerate liquid ≤14 days.
• PT-141: Room temp stable short-term; refrigerate reconstituted ≤1 week.

Subcutaneous Peptide Injection Protocol

Subcutaneous Peptide Injection Protocol Overview

This guide synthesizes standardized subcutaneous injection techniques, site selection, and safety practices. Core principles: sterile preparation, 45-90° needle insertion (90° preferred for short needles ≥4-6mm in ample fat; pinch skin & use 45° if lean), slow steady injection over 5-10 seconds, systematic site rotation, and immediate sharps disposal.

Preparation & Supplies

• Hand Hygiene: Wash thoroughly with soap and water.
• Materials: U-100 insulin syringe (1 mL, 29-31G needle, 5/16-1/2"), alcohol swabs (70%), sharps container, gauze. Use 30-50 unit syringes for volumes <10 units.
• Vial Prep: Wipe stopper, dry 10-30 seconds, draw dose, tap out air bubbles. Warm vials to room temperature to reduce stinging.
• Volume Limit: ≤1.5 mL per site; split larger doses (e.g., 75 IU into 3x25 IU). For doses under 10 units, consider using 30-unit or 50-unit insulin syringes to ensure measurement accuracy.

Site Selection & Rotation

Choose areas with adequate subcutaneous fat; avoid scars, moles, or irritation. Systematically rotate sites 1-1.5 inches apart; avoid same spot for 1-2 weeks. Log sites to prevent lipohypertrophy/lumping:

• Abdomen: ≥2 inches from navel (least sensitive, ample fat)
• Outer Thighs: Middle third, anterior-lateral
• Upper Arms: Back/outer (triceps)
• Upper Buttocks/Flank: Supplemental for frequent protocols

Peptide Injection Technique

Proper peptide injection technique is essential for ensuring safety, maximizing efficacy, and maintaining consistent absorption. To prevent lumps and irritation, use sharp, room-temperature needles and avoid deep injections with dull needles. Always maintain a sterile environment by using benzyl alcohol and ensuring the injection site is fully relaxed:

1. Clean site outward in circles; air-dry 30 seconds.
2. Pinch 1-2 inch skin fold to lift subcutaneous layer.
3. Insert needle at 45-90° angle (90° for ample fat, 45° for lean/thin needle).
4. No aspiration (pulling back plunger to check for blood)
5. Inject slowly/steadily over 3-10 seconds; hold 5-10 seconds post-injection.
6. Withdraw at same angle; gentle pressure if bleeding.
7. Dispose in sharps container immediately; never recap.
8. Discard any reconstituted solution if it becomes cloudy. Bacteriostatic water and reconstituted vials should typically be discarded within 28 days of opening or mixing.

Peptide Injection Timing Consideration

• Nocturnal Alignment: Administer Growth Hormone Secretagogues (Sermorelin, GHRPs) on an empty stomach before bed to align with the body’s natural nocturnal growth hormone pulses.
• Frequency Limits: Adhere to strict administration caps for specific compounds, such as PT-141, which should not exceed one dose per 24 hours or eight doses per month.
• Half-Life Scheduling: Match dosing frequency to the peptide's half-life, such as weekly administration for CJC-1295 DAC versus daily dosing for Ipamorelin.
• Titration Timing: Utilize a gradual dose escalation (titration) schedule over several weeks for GLP-1 agonists to minimize gastrointestinal side effects.
• Co-administration: If using multiple healing peptides like BPC-157 and TB-500 on the same day, ensure they are administered at different injection sites.
• Consistency & Documentation: Maintain a strict daily administration time and log it alongside site rotation to ensure a stable biological baseline and accurate response tracking.

Peptide Post-Injection Care & Risks

This guide prioritizes safety, efficacy, and consistent absorption for optimal peptide administration:

• Monitor for redness/swelling; rest site 1-7 days if severe.
• No massage (disrupts absorption).
• Document dose, site, time, reactions.
• Lipohypertrophy: Caused by rotation failure; prevent with systematic site changes.
• Pain/Lumps: From deep injection, cold solution, or dull needles.
• Infection: Maintain asepsis; monitor for fever/redness.

Carnitine – Identification

Common Names and Designations:

• L-Carnitine (primary designation; L-enantiomer is biologically active)

• Carnitine (general designation)

• 3-Hydroxy-4-trimethylammonium butanoate (chemical nomenclature)

• γ-Trimethyl-β-hydroxybutyrobetaine (alternative nomenclature)

• Vitamin BT (historical designation; no longer used)

• D,L-Carnitine (racemic form; contains both D and L enantiomers)

CAS Number: 541-15-1 (L-carnitine); 2776-76-7 (D-carnitine)

Molecular Formula: C₇H₁₅NO₃

Molecular Weight: 161.20 Da (or 161.20 g/mol)

PubChem CID: 848 (L-carnitine); 439400 (D-carnitine)

Origin and Classification:

• Source: Natural; synthesized endogenously in liver and kidneys; dietary sources include animal products (beef, lamb, pork), some plant foods contain small amounts

• Biosynthesis: Multi-step enzymatic synthesis from amino acids lysine and methionine; requires vitamin C (ascorbic acid), iron (Fe²⁺), and α-ketoglutarate as cofactors

• Functional Classification: Metabolic cofactor; bioenergetic compound; cellular energy modulator; fatty acid transporter

• Structural Type: Small organic zwitterion; quaternary ammonium compound (positively charged trimethylammonium group; negatively charged carboxyl group)

Chemical Structure:

• Molecular backbone: 4-carbon chain (butanoate)

• Functional groups: Hydroxyl group (-OH) at position 3; trimethylammonium group (-N(CH₃)₃⁺) at position 4; carboxyl group (-COO⁻) at position 1

• Charge: Zwitterionic at physiological pH (7.4); overall neutral charge despite presence of charged functional groups

• Enantiomers: L-carnitine is biologically active; D-carnitine is largely inactive or has minimal activity; DL-carnitine (racemic) contains 50% L-carnitine

Physicochemical Properties:

• Appearance: White to off-white crystalline powder

• Solubility: Highly soluble in water (~270 mg/mL at 25°C); soluble in ethanol; slightly soluble in acetone

• Melting Point: Approximately 196-198°C (L-carnitine)

• pH: Approximately 5.5-7.0 for aqueous solutions depending on concentration and buffering

• Stability: Stable at room temperature; stable in acidic and neutral pH; unstable in highly alkaline conditions

• Optical Rotation: [α]D = +1.8° to +2.0° (for L-carnitine in aqueous solution)

• pKa values: Approximately 3.0 (carboxyl group) and 11.8 (ammonium group)

Salt Forms and Formulations:

• L-Carnitine free base: Used in some formulations

• L-Carnitine L-tartrate: Salt form providing enhanced stability and solubility; commonly used in pharmaceutical and supplement formulations

• Acetyl-L-carnitine (ALCAR): Acetylated derivative; crosses blood-brain barrier more readily; used for neurological applications

• Propionyl-L-carnitine: Propionylated derivative; maintains acyl-carnitine pool; used in cardiovascular research

• Pharmaceutical preparations: Supplied as capsules, tablets, liquids, and injectable solutions (in clinical settings for carnitine deficiency)

Biochemical Properties:

• Biosynthetic pathway: Lysine → ε-N-trimethyllysine (via lysine trimethylaminotransferase) → 3-hydroxy-ε-N-trimethyllysine (via 3-hydroxybutyrate oxidase) → 4-trimethylammonium-3-oxobutanoate → L-carnitine (via 4-trimethylammonium-3-oxobutanoate hydroxylase)

• Cofactor requirements: Vitamin C (ascorbic acid), Fe²⁺, α-ketoglutarate, NAD(P)H

• Rate-limiting step: Activity of γ-butyrobetaine hydroxylase (final enzyme in synthesis); activity affected by vitamin C and iron availability

• Circulating levels (reference ranges): Approximately 40-60 μmol/L in adults; varies by age, nutritional status, and renal function

Protein Interaction:

• Carnitine Palmitoyltransferase I (CPT-I): Membrane-associated enzyme catalyzing the esterification of carnitine with long-chain fatty acyl-CoA; rate-limiting step in mitochondrial fatty acid import

• Carnitine-Acylcarnitine Translocase: Inner mitochondrial membrane transporter mediating carnitine/acylcarnitine antiport

• Carnitine Palmitoyltransferase II (CPT-II): Inner mitochondrial matrix enzyme releasing acyl group from acylcarnitine, regenerating CoA for beta-oxidation

• Carnitine transporters (OCTN2, OCTN1): Membrane proteins mediating carnitine reabsorption in kidney, uptake in tissues

Production and Supply:

• Endogenous synthesis: Approximately 14 mg/day synthesized endogenously in humans under normal conditions

• Dietary sources: Beef (~430 mg/200g), lamb (~150 mg/200g), pork (~83 mg/200g), chicken (~5 mg/200g), dairy products (~1-5 mg/serving); minimal in plant foods

• Commercial production: Chemical synthesis for pharmaceutical and supplement use; biosynthetic production using engineered microorganisms

• Quality standards: USP (United States Pharmacopeia), European Pharmacopoeia specifications available

Pharmacological Classification:

• Metabolic cofactor

• Bioenergetic compound

• Fatty acid transporter

• Nutritional supplement

• Therapeutic agent (in deficiency conditions)

Regulatory Status:

• FDA: L-carnitine approved for treatment of primary and secondary carnitine deficiency (prescription medication)

• Supplement status: Available over-the-counter as dietary supplement in many countries

• Clinical use: Approved in some countries for cardiac and metabolic disorders

• Sports use: Legal supplement; subject to regulations in competitive sports

Database Links and External References:

• PubChem: CID 848 (L-carnitine) - Complete chemical structure and properties

• HMDB (Human Metabolome Database): HMDB0000062 - Comprehensive metabolic information

• DrugBank: DB00157 - Clinical and biochemical information

• KEGG: C00318 - Metabolic pathway integration

Note: Carnitine's quaternary ammonium structure and zwitterionic nature distinguish it as a unique metabolic cofactor. Unlike amino acids with free amino and carboxyl groups, carnitine's fixed positive charge (trimethylammonium) and fixed negative charge (carboxylate) make it highly polar and water-soluble, essential for its function in aqueous cellular environments and as a carrier molecule. The distinction between biologically active L-carnitine and inactive D-carnitine is crucial for therapeutic applications—only L-carnitine should be used clinically and in supplementation.

Carnitine – Research

Carnitine is like a shuttle in your body that helps move fats into the cell's power plants (called mitochondria) so they can be burned for energy. It's found in foods like meat and can be taken as a supplement. Studies show it helps with heart health, energy levels, exercise performance, and conditions where the body doesn't make enough on its own. Here are four key research findings from trusted sites like PubMed and NIH. Each has the study title, benefits, only the link, and a simple summary.

Study: Therapeutic effects of L-carnitine and propionyl-L-carnitine on cardiovascular diseases: a review
Benefits: Improves heart function after heart attacks, reduces irregular heartbeats, and helps with chest pain by better using fats and sugars for energy.
Link: https://pubmed.ncbi.nlm.nih.gov/15591005/
Summary: This review looked at how carnitine protects the heart during low oxygen times, like in a heart attack or bypass surgery. It stops harmful fat buildup in heart cells and helps switch to sugar burning when fats are a problem. In big trials with hundreds of patients, giving carnitine right after a heart attack (by IV then pills) cut down heart muscle damage, improved pumping strength, and lowered risks of heart failure or death. Patients had less remodeling (heart changing shape badly) and better recovery. It's safe and works by fixing energy production inside heart cells, making it a helpful add-on for heart patients.

Study: Carnitine: The Science Behind a Conditionally Essential Nutrient
Benefits: Boosts heart recovery after attacks, helps kidney patients on dialysis feel better, and supports muscle energy without major side effects.
Link: https://ods.od.nih.gov/News/Carnitine_Conference_Summary.aspx
Summary: Experts at an NIH conference reviewed tons of studies on carnitine. It's key for burning fats in muscles and heart, especially when the body can't make enough (like in kids with genetic issues or dialysis patients). Italian trials with thousands showed IV carnitine after heart attacks lowered deaths and heart failure. It raises carnitine levels in tissues, fights toxic fats, and improves energy. For dialysis, it fixes low levels causing tiredness. No big risks at normal doses, but more trials needed for healthy people wanting weight loss or better workouts. Great for "conditionally essential" cases where diet isn't enough.

Study: L-carnitine--metabolic functions and meaning in humans life
Benefits: Helps burn fat for energy, reduces tiredness from illness or exercise, and fights cell damage from stress.
Link: https://pubmed.ncbi.nlm.nih.gov/21561431/
Summary: This paper explains carnitine's job in turning fats into fuel, made from amino acids in liver/kidneys or from foods like beef. Low levels cause fatigue because fats pile up instead of burning. Supplements help heart failure, angina, and weight loss by cutting oxidative stress (cell rust). It didn't boost healthy athletes much but aids sick or tired folks. Safe overall, but needs more studies on who benefits most—like vegetarians low on it. Keeps metabolism smooth, preventing energy crashes and supporting daily life.

Study: Comprehensive review of the expanding roles of the carnitine pool in metabolic physiology: beyond fatty acid oxidation
Benefits: Protects organs like heart, liver, kidneys from damage; fights inflammation, improves insulin use, and supports brain health.
Link: https://pmc.ncbi.nlm.nih.gov/articles/PMC11907856/
Summary: This big review covers carnitine's extra jobs beyond fat burning: balancing energy in organs, fixing mitochondria (cell power plants), and acting as signals between cells. Low carnitine links to diabetes, heart disease, and nerve issues; supplements help in animal tests by cutting swelling, boosting antioxidants, and aiding muscle recovery. In people, it shows promise for liver fat, kidney protection, and even cancer tiredness. Acylcarnitines (fatty versions) act as disease markers. Highlights whole-body teamwork, like gut-liver links, for better health strategies.

Carnitine – Research Links